Market Value477,799,472
Total Holdings40
File Date2024-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CLYM / Climb Bio, Inc.
ALLK / Allakos Inc.
STRO / Sutro Biopharma, Inc.
HLVX / HilleVax, Inc.
IOBT / IO Biotech, Inc.
IGMS / IGM Biosciences, Inc.
KRON / Kronos Bio, Inc.
AVADEL PHARMACEUTICALS PLC / SPONSORED ADR (05337M104)
LPTX / Cypherpunk Technologies Inc.
JSPR / Jasper Therapeutics, Inc.
PRME / Prime Medicine, Inc.
INZY / Inozyme Pharma, Inc.
SYRS / Syros Pharmaceuticals, Inc.
ADVM / Adverum Biotechnologies, Inc.
VTVT / vTv Therapeutics Inc.
GOSS / Gossamer Bio, Inc.
NKTX / Nkarta, Inc.
JANX / Janux Therapeutics, Inc.
IMTX / Immatics N.V.
DAWN / Day One Biopharmaceuticals, Inc.
BOLT / Bolt Biotherapeutics, Inc.
TNGX / Tango Therapeutics, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
SLRN / Acelyrin, Inc.
NGNE / Neurogene Inc.
CTNM / Contineum Therapeutics, Inc.
ZYME / Zymeworks Inc.
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
LENZ / LENZ Therapeutics, Inc.
ACLX / Arcellx, Inc.
MLYS / Mineralys Therapeutics, Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
SRZNW / Surrozen, Inc. - Equity Warrant
TERN / Terns Pharmaceuticals, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
AVDL / Avadel Pharmaceuticals plc
SRRK / Scholar Rock Holding Corporation
CRGX / CARGO Therapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc.
LYRA / Lyra Therapeutics, Inc.
VIRX / Viracta Therapeutics, Inc.
ALVR / AlloVir, Inc.